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Abstract
Intracellular transport and egress of alphaherpesviruses require the coordinate function of multiple proteins and glycoproteins. Recently,
we showed that gK is expressed on infected cell surfaces and that gK cell-surface expression required the presence of the UL20 protein
[J. Virol. 77 (2003), 499]. Overexpression of gK by gK-transformed cells blocked transport of enveloped virions from perinuclear spaces
and inhibited virus-induced cell fusion caused by gK syncytial mutants [J. Virol. 69 (1995), 5401]. Therefore, we investigated whether
altered synthesis and transport of gK was responsible for the observed gK-mediated interference phenomena. HSV-1 infection of the
gK-transformed cell line Vero (gK9) caused a profound entrapment of gK in the endoplasmic reticulum and total inhibition of gK cell
surface expression. In addition, gK drastically inhibited intracellular transport and maturation of gD and caused substantial defects in
Golgi-dependent glycosylation of gB. Visualization of intracellular organelles via confocal microscopy revealed a profound collapse of the
Golgi apparatus into the endoplasmic reticulum. These results were analogous to those observed in the presence of brefeldin A, a known
Golgi disruptor. Therefore, virion entrapment within perinuclear spaces and inhibition of glycoprotein transport are due to gK-mediated
collapse of the Golgi apparatus.
© 2003 Elsevier Inc. All rights reserved.
Introduction
The prevailing model for herpesvirus morphogenesis and
egress of infectious virions into the extracellular spaces
involves multiple steps including: (1) primary envelopment
by budding of virion capsids assembled in the nuclei
through the inner nuclear leaflet; (2) de-envelopment by
fusion between viral envelopes and the outer nuclear leaflet;
(3) re-envelopment of cytoplasmic capsids into Golgi or
TGN-derived vesicles (reviewed in Johnson and Huber,
2002; Mettenleiter, 2002; Tomishima et al., 2001). There-
fore, final steps in virion morphogenesis necessitate the
targeted localization of viral membrane proteins and glyco-
proteins within these cytoplasmic organelles. Herpes sim-
plex viruses (HSV) specify at least 11 virally encoded
glycoproteins as well as several nonglycosylated mem-
brane-associated proteins, which are synthesized in the en-
doplasmic reticulum and transported to the plasma mem-
brane via the Golgi apparatus, presumably following
cellular vesicular transport pathways (Griffiths and Simons,
1986; Roizman and Sears, 1996; Rothman, 1994, 1996;
Rothman and Wieland, 1996). Intracellular transport of viral
proteins and glycoproteins to Golgi and cell surfaces en-
hances virus spread through virus-induced cell fusion and
other mechanisms. Furthermore, localization of viral glyco-
proteins in intracellular compartments such as the Golgi is
necessary for late events in virion morphogenesis (Roizman
and Sears, 1996; Spear, 1993b).
Cell-to-cell transmission of herpes simplex virus type-1
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(HSV-1) occurs either by release of virions to extracellular
spaces or through virus-induced cell-to-cell fusion. Wild-
type (syn) virions spread across cellular junctions of jux-
taposed membranes and cause rounding and aggregation of
cells as well as limited virus-induced cell fusion. Certain
spontaneous mutants of HSV-1 (syn) can rapidly spread into
adjacent cells by inducing the formation of large multinu-
cleated cells or syncytia. Mutations that cause extensive
virus-induced cell fusion have been mapped to at least four
regions of the viral genome: the UL20 gene (Baines and
Roizman, 1991; MacLean et al., 1991), the UL24 gene
(Jacobson et al., 1998; Sanders et al., 1982), the UL27 gene
encoding glycoprotein B (gB) (Bzik et al., 1984; Pellett et
al., 1985), and the UL53 gene coding for glycoprotein K
(gK) (Bond and Person, 1984; Debroy et al., 1985; Hutchin-
son et al., 1992; Pogue-Geile et al., 1984; Ryechan et al.,
1979). However, syncytial mutations (syn) in the UL53
gene are more frequently isolated than in any other gene
(Bond and Person, 1984; Bond et al., 1982; Dolter et al.,
1994; Pogue-Geile et al., 1984; Pogue-Geile and Spear,
1987; Read et al., 1980; Ryechan et al., 1979).
HSV-1 gK is a highly hydrophobic 338-amino acid gly-
coprotein encoded by the UL53 open reading frame (De-
broy et al., 1985; Hutchinson et al., 1992; McGeoch et al.,
1988; Pogue-Geile and Spear, 1987; Ramaswamy and Hol-
land, 1992). Mutant viruses that are deficient in gK expres-
sion have been isolated and characterized for HSV-1, pseu-
dorabies virus (PRV), and varicella-zoster virus (Foster and
Kousoulas, 1999; Hutchinson and Johnson, 1995; Jayachan-
dra et al., 1997; Klupp et al., 1998; Mo et al., 1999).
Deletion of HSV-1 and PRV gK resulted in a small plaque
phenotype, substantially reduced the production of infec-
tious virions, and inhibited virion translocation from the
cytoplasm to the extracellular space (Foster and Kousoulas,
1999; Hutchinson and Johnson, 1995; Jayachandra et al.,
1997; Klupp et al., 1998). Recently, we reported that gK is
a structural component of HSV-1 virions and functions in
virus entry (Foster et al., 2001b). Furthermore, gK was
localized both within Golgi and on infected cell surfaces
and required transport to cell surfaces for gK-mediated
virus-induced cell-to-cell fusion (Foster et al., 2003). Golgi-
dependent glycosylation and cell-surface expression of gK
required coexpression of the UL20 protein suggesting pos-
sible interactions between gK and UL20 (Dietz et al., 2000;
Foster et al., 2003). Collectively, these studies have indi-
cated that gK is essential for virion morphogenesis and
egress of alphaherpesviruses.
It was first reported by Hutchinson et al. that HSV-
enveloped particles accumulated within the perinuclear
spaces of cells overexpressing the gK gene, and that syn-
cytial mutants in gK did not induce cell-to-cell fusion
(Hutchinson et al., 1993; Hutchinson and Johnson, 1995). In
the current article, we build upon these initial findings by
employing newly developed methodologies for detecting
and tracking gK within infected cells and on cell surfaces as
well as simultaneously assessing intracellular organelle
structures. It was found that overexpression of gK resulted
in collapse of the Golgi apparatus leading to severe defects
in virus egress and synthesis, maturation, and transport of
viral glycoproteins.
Results
Phenotypic and replication characteristics of KOS, MP,
and tsB5 strains in Vero- and gK-transformed cells
Previously, Hutchinson et al. constructed and charac-
terized gK-transformed cell lines Vero(gK9) and
Vero(VK302), containing approximately 200 and 1 copies
of gK under control of the HSV-1 gD promoter, respec-
tively, resulting in approximately 17-fold higher gK expres-
sion in gK9 cells relative to HSV-1 infection of Vero cells
(Hutchinson et al., 1993; Hutchinson and Johnson, 1995).
VK302 cells were shown to effectively complement gK-null
viruses F-gK and gK for virus replication and cell-to-cell
spread and were instrumental for their isolation and propa-
gation (Hutchinson and Johnson, 1995; Jayachandra et al.,
1997). In contrast, the gK9 cell line failed to complement
gK-null virions and inhibited fusion caused by viruses con-
taining syncytial mutations within the UL53-gK gene
(Hutchinson et al., 1993; Hutchinson and Johnson, 1995).
The relative levels of gK expression were assessed in the
absence or presence of viral infection by quantitative real-
time RT-PCR. The relative amounts of gK mRNAs were
normalized to the gK mRNA levels of either uninfected
Vero cells or Vero cells infected with KOS (Table 1). In the
absence of viral infection, gK mRNAs were synthesized in
VK302 and gK9 cells at very low levels and at nearly
equivalent amounts. KOS-infected VK302 cells produced
approximately 1.6-fold higher amounts of gK than KOS-
infected Vero cells. In contrast, KOS-infected gK9 cells
produced approximately 24-fold higher amounts of gK
mRNAs than KOS-infected Vero cells (Table 1). These
results are in agreement with previous estimations of 17-
fold more gK protein expressed in gK9 cells infected with
HSV-2 (Hutchinson et al., 1993).
To assess the effects of gK on cell-to-cell spread and
Table 1
Fold differences in gK expressiona
Test sample Avg.
CT
CT Std.
Dev.
Relative to
Verob
Relative to
Vero-KOSb
Vero 17.7 0.4 1.0 N/A
VK302 16.1 0.3 2.9 N/A
gK9 16.2 0.9 2.8 N/A
Vero-KOS 7.4 0.2 N/A 1.0
VK302-KOS 6.7 0.5 N/A 1.6
gK9-KOS 2.8 0.5 N/A 24
a Abbreviations: Avg. average; Std. Dev.  standard deviation.
b For calculations see materials and methods.
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viral replication, we examined the plaquing efficiency,
plaque morphology, and kinetics of viral replication for
KOS, MP(gKsyn20), and tsB5(gBsyn3) viral strains in
Vero, VK302, and gK9 cells. The relative plaquing efficien-
cies of all three viruses were drastically inhibited in gK9
cells by 200- to 1000-fold, and partially inhibited in VK302
cells by approximately 1.6- to 2-fold (Table 2). The reduc-
tion in relative plaquing efficiencies of all three viruses
correlated with the relative amounts of gK mRNAs detected
by quantitative RT-PCR as shown in Table 1, indicating that
overproduction of gK caused inhibition of viral replication.
To better assess the effect of gK overproduction on virus
replication, we evaluated the viral replication kinetics of
KOS, MP, and tsB5 in Vero, VK302, and gK9 cells. All
three viruses replicated with similar efficiencies in Vero and
VK302 cells (Fig. 1A, B, and C). In contrast, in gK9 cells,
all three viruses exhibited slower kinetics of viral replica-
tion and produced titers, which were reduced by at least
1.5-logs at 24 hpi (Fig. 1A, B, and C) relative to the same
virus on Vero cells. Therefore, infectious virus production
was drastically inhibited in gK9 cells in comparison to
VK302 and Vero cells.
In addition to inhibition of viral replication, substantial
changes in plaque morphology of wild-type and syncytial
mutant viruses were observed in gK9 cells. MP and tsB5,
which contain syncytial mutations in gK and gB respec-
tively, produced large syncytial plaques in both Vero and
VK302 cells (Fig. 2B1, B2, C1, and C2). Similarly, KOS
generated wild-type plaques in both Vero and VK302 cells
(Fig. 2A1 and A2). In comparison, both KOS and MP
infections of gK9 cells produced mostly single infected cells
or small, nonsyncytial plaques containing 10–20 cells (Fig.
2A3 and B3, respectively). The small, nonsyncytial plaque
phenotype of MP in gK9 cells suggested that overexpres-
sion of gK inhibited virus-induced cell fusion and virus
spread. In contrast, infection of gK9 cells with tsB5 virus
produced syncytial plaques, which were on average 50%
smaller than those formed in either Vero or VK302 cells
(Fig. 2C3). While gB-mediated cell-to-cell fusion was not
drastically inhibited, overexpression of gK did affect the
extent of gB-mediated cell fusion, suggesting that either
cell-to-cell spread or viral replication of gBsyn viruses was
affected. Similar results were obtained with the KOS syn-
geneic virus strains KOS(syn3) and KOS(syn20), contain-
ing the syn3 mutation in gB and the syn20 mutation in gK,
respectively (not shown).
Intracellular distribution of KOS, MP, and tsB5 virions in
gK-transformed cells is similar to the distribution of
virions in cells treated with inhibitors of glycoprotein
synthesis and transport
To assess the intracellular distribution and morphology
of virions in gK9 cells, we examined cells infected with
different viruses by electron microscopy. Virion particles
within KOS-infected Vero and VK302 cells showed a sim-
ilar cellular distribution (Fig. 3A and B, respectively). En-
veloped virion particles were localized both within intracel-
lular vacuoles (Fig. 3A), as well as on cell surfaces (Fig. 3A
and B). Despite the fusogenic nature of both tsB5 and MP,
infected Vero cells exhibited a similar intracellular and cell
surface distribution to that of wild-type KOS {Fig. 3D and
E (tsB5) and G and H (MP)}. Interestingly, cytoplasmic
vacuoles were not present in MP-infected Vero cells (Fig.
3G and H). Instead, enveloped virions were found stacked
within distinct tubular structures throughout the cytoplasm
(Fig. 3H). Neither capsids within the cytoplasm nor envel-
oped virions within perinuclear spaces were frequently en-
Table 2
Relative plaque efficiency on Vero- and gK-expressing cell linesa
Virus Relative number of viral plaques
Vero VK302 gK9
KOS 100.00 57.67 0.15
tsB5 100.00 51.98 0.10
MP 100.00 69.97 0.50
a The titers of KOS, tsB5, or MP viruses determined on Vero cells were
defined as 100% and the relative plaquing efficiency for each virus on
VK302 and gK9 cells was calculated.
Fig. 1. Comparison of virus replication characteristics of KOS (A), MP (B), and tsB5 (C) on Vero (F), VK302 (E), or gK9 cells (). One-step kinetics of
infectious virus production were calculated after infection at an MOI of 5 followed by incubation at 37°C.
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countered in all infected Vero and VK302 cells examined
(Fig. 3A, B, D, E, G, and H). In contrast, KOS- and MP-
infected gK9 cells were devoid of both cytoplasmic and
extracellular virions (Fig. 3C and I, respectively), while
enveloped virions were observed exclusively within perinu-
clear spaces (Fig. 3C, I, and inset within panel C). Con-
versely, tsB5-infected gK9 cells did not exhibit a significant
number of virions trapped within perinuclear spaces (Fig.
3F). Although there were no virion particles found in the
extracellular space, enveloped virions were localized within
cytoplasmic vacuoles, and a high number of unenveloped
capsids were present within the cytoplasm of tsB5-infected
gK9 cells (Fig. 3F). Similar results were produced by KOS
(syn3) and KOS (syn20) viruses (not shown).
Similar virus transport defects have been observed with
certain HSV mutants that exhibit altered glycoprotein trans-
port, as well as with viruses incubated in the presence of
chemical inhibitors that block glycoprotein transport and pro-
cessing (Johnson and Spear, 1982; Kousoulas et al., 1983a,
1983b; Pizer et al., 1980; Whealy et al., 1991). Collectively,
these studies have shown that intracellular virion transport and
morphogenesis require intact glycoprotein synthesis and trans-
port pathways. Therefore, we compared the intracellular dis-
tribution of virions in gK9 cells to those obtained in the pres-
ence of specific inhibitors of glycoprotein maturation. Infected
Vero cells were treated with the glycoprotein inhibitors tuni-
camycin (TM), brefeldin A (BFA), or monensin, and intracel-
lular virions were visualized by EM at 16 hpi. TM inhibits the
en bloc transfer of N-linked carbohydrates onto polypeptide
backbones of glycoproteins (Kousoulas et al., 1983; Pizer et
al., 1980; Takatsuki et al., 1971; Tkacz and Lampen, 1975),
while BFA causes redistribution of Golgi membranes into the
ER (Cheung et al., 1991; Doms et al., 1989; Whealy et al.,
1991). Both inhibitors effectively limit transport and process-
ing of glycoproteins to the endoplasmic reticulum. In compar-
ison, monensin inactivates ionic gradients required for the
Fig. 2. Plaque morphology of KOS (A), MP (B), or tsB5 (C) viruses on Vero (A1, B1, and C1), VK302 (A2, B2, and C2), or gK9 cells (A3, B3, and C3).
Confluent cell monolayers were infected at an MOI of 0.001 and visualized by fluorescence microscopy at 36 hpi. Panels A1, A2, A3, and B3 were
photographed at 10 magnification, while panels B1, B2, C1, C2, and C3 were photographed at 5 magnification.
240 T.P. Foster et al. / Virology 317 (2003) 237–252
proper function of Golgi-localized enzymes, causing inhibition
of glycoprotein transport and accumulation of glycoproteins
within Golgi-derived vesicles (Johnson and Spear, 1982; Kou-
soulas et al., 1983b). As expected, all three chemical inhibitors
prevented egress of virions to extracellular spaces (Fig. 4B, C,
and D), relative to mock-treated infected Vero cells (Fig. 4A).
Inhibition of glycoprotein transport from the ER to Golgi,
using either TM or BFA, caused accumulation of virion par-
ticles in the perinuclear spaces, which was similar to the inhi-
bition of virion egress found in gK9 cells (Fig. 4B and C). In
contrast, inactivation of Golgi-dependent glycosylation with
monensin caused entrapment of virion particles within cyto-
plasmic vesicles (Fig. 4D). These results suggested that inhi-
bition of glycoprotein synthesis and transport from ER to Golgi
may be associated with the perinuclear entrapment of virions in
gK9 cells.
Characterization of cell surface expression of viral
glycoproteins in Vero- and gK-transformed cells
In the absence of viral infection, gK9 and VK302 cells
produced very low and equivalent levels of gK (Table 1). To
Fig. 3. Electron micrographs of Vero (A, D, E, G, and H), VK302 (B), or gK9 (C, F, and I) cells infected with either KOS (A, B, and C), tsB5 (D, E, and
F), or MP (G, H, and I) viruses. Confluent cell monolayers were infected at an MOI of 5, incubated at 37°C for 16 h, and prepared for transmission electron
microscopy. Nucleus (N), cytoplasmic (C), and extracellular (E) spaces are marked. Bar  1.0 m; bar in inset  0.2 m.
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ascertain whether gK9 cells specified an inherent defect in
glycoprotein synthesis and transport, gK9, Vero, and
VK302 cells were transfected with a plasmid capable of
expressing both gB and gD (Browne et al., 2001; Foster et
al., 2001a, 2003). Western blot analysis of gB and gD
expression, glycosylation, and transport in these cells indi-
cated that gK9, Vero, and VK302 cells produced similar
amounts of fully glycosylated gD and gB (Fig. 5). Similarly,
immunofluorescence analysis of gK9, Vero, and VK302
cells transiently expressing gB and gD revealed equivalent
intracellular and cell surface distributions (data not shown).
Thus, in the absence of viral infection, gK9 cells did not
exhibit any defects in viral glycoprotein synthesis or trans-
port to cell surfaces. In contrast, confocal microscopic ex-
amination of the intracellular distribution of viral glycopro-
teins in infected gK9 cells showed a drastic inhibition of
intracellular transport and cell surface expression (Fig. 6).
Glycoproteins gD, gB, and gK were efficiently transported
to infected Vero cell surfaces (Fig. 6A3, C3, and E3).
Transport of gK to gK9-infected cell surfaces was com-
pletely inhibited (Fig. 6F3), while transport of gD was
significantly, but not completely inhibited (Fig. 6B3). gD
and gK assumed a more juxtanuclear distribution in gK9
cells, consistent with inhibition of transport at the ER (Fig.
6B1, and F1, respectively). Interestingly, gB was efficiently
transported to infected gK9 cell surfaces (Fig. 6D3). To
further strengthen these findings, the relative amounts of
cell surface expressed gD and gK exposed to extracellular
spaces were assessed using immunohistochemistry under
live and fixed conditions as we have described previously
Fig. 4. Electron micrographs of Vero cells infected with KOS and either treated with TM (B), BFA (C), monensin (D), or mock-treated (A). Cells were
infected with KOS at an MOI of 5 and inhibitors were added at 3 hpi. Incubation of infected cells was continued at 37°C for 16 h. Nucleus (N), cytoplasmic
(C), and extracellular (E) spaces are marked. Arrows indicate enveloped virions trapped within perinuclear spaces. Bar  1.0 m.
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(Foster et al., 2003). In agreement with the confocal mi-
croscopy results, immunohistochemical detection of gD and
gK showed that gK was absent from infected gK9 cell
surfaces (Fig. 7C3), while gD was greatly reduced (Fig.
7C1). Similar to the confocal microscopy results, fixed and
permeabilized gK9 cells stained for either gD or gK showed
a concentrated perinuclear staining (Fig. 7C2 and C4, re-
spectively). This distribution was similar to the observed
tunicamycin-induced glycoprotein transport defect, which
we described previously (Foster et al., 2003). In compari-
son, gD and gK cell surface expression was not affected in
VK302 cells (Fig. 7B1 and B3, respectively) relative to
infected Vero cells (Fig. 7A1 and A3).
Identification of the cellular block in glycoprotein
transport in gK9 cells
Confocal microscopy and immunohistochemistry exper-
iments indicated a perinuclear block in viral glycoprotein
transport for gD and gK, most likely within the endoplasmic
reticulum, in a manner analogous to either TM or BFA
treatment. Therefore, glycoprotein processing and intracel-
lular distribution within infected cells were examined. The
synthesis and transport of viral glycoproteins gD, gB, and
gK were determined by characterizing their Golgi-depen-
dent glycosylation using the glycosidases endoglycosidase
H (EndoH) and peptide-N-glycosidase F (PNGaseF). En-
doH specifically cleaves immature carbohydrates that have
been added within the ER and not yet processed by Golgi
(Maley et al., 1989; Robbins et al., 1984); whereas, PN-
GaseF cleaves all N-linked carbohydrates from their
polypeptide backbone independent of the extent of glyco-
sylation (Maley et al., 1989; Plummer and Tarentino, 1991).
Vero- and VK302-infected cells contained EndoH-sensitive
Fig. 5. Characterization of the synthesis and processing of transiently
expressed gD and gB in Vero, VK302, or gK9 cells. Immunoblots of
cellular extracts from transfected cells were reacted with either anti-gD or
anti-gB monoclonal antibodies.
Fig. 6. Confocal microscopic visualization of cell surface and intracellular distribution of gD (A and B), gB (C and D), and gK (E and F) in either Vero (A,
C, and E) or gK9 (B, D, and F) cells infected with gKV5DI at an MOI of 5. Infected cell surfaces were labeled with biotin (red) under live conditions. Cells
were fixed and processed for confocal microscopy and labeled with anti-gD (green: A1, A3, B1, and B3), anti-gB (green: C1, C3, D1, and D3), or anti-V5
(green: E1, E3, F1, and F3) as well as with TO-PRO3, which specifically labels nuclei (blue: A3, B3, C3, D3, E3, and F3). Superimpositions of red, green,
and blue images for each group are shown (A3, B3, C3, D3, E3, and F3).
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and resistant forms of gD, gB, and gK (Fig. 8A, B, and C).
In contrast, infected gK9 cells produced gD, gB, and gK
species that migrated with electrophoretic mobilities con-
sistent with that of immature glycoproteins (Fig. 8A, B, and
C, mock-treated lanes). Furthermore, gD, gB, and gK ex-
pressed in gK9 cells were susceptible to EndoH treatment
(Fig. 8A, B, and C, EndoH lanes) indicating that the block
in protein transport was exerted either at the endoplasmic
reticulum or the cis phase of the Golgi. Previously, we
showed that treatment of HSV-1-infected Vero cells with
TM prevented glycosylation of gK, gB, and gD glycopro-
teins, while treatment with brefeldin A (BFA) produced
high-mannose, EndoH-sensitive precursors of these glyco-
proteins (Browne et al., 2001; Foster et al., 2001a, 2003).
Therefore, the observed processing defects of gK, gB, and
gD in gK9 cells are analogous to those observed after
treatment with brefeldin A.
Both gD and gK colocalized with the ER organelle
marker concanavalin A (conA) (Cottin et al., 1999; Lee et
al., 2000) in infected gK9 cells (Fig. 9A and B). This
distribution pattern paralleled both gK and gD colocaliza-
tion at the endoplasmic reticulum in Vero cells treated with
either BFA (Fig. 9C) or TM (Fig. 9E). Treatment with either
BFA or TM inhibited cell surface expression of gK and gD
(Fig. 9D and F, respectively). However, glycoprotein local-
ization patterns obtained under BFA treatment more closely
resembled the distribution of viral glycoproteins in gK9-
infected cells.
Assessment of Golgi and ER structures in Vero and gK9
cells
Confocal microscopy experiments revealed aberrant dis-
tribution of Golgi markers. Golgi and ER organelles were
visualized after staining with lectin GS-II (Golgi/green) or
conA (ER/red), as described previously (Foster et al., 2003;
Cottin et al., 1999; Lee et al., 2000). Classic patterns of
perinuclear localized curvilinear Golgi structures were vi-
sualized in mock-infected, Vero, and gK9 cells (Fig. 10A).
Infection of Vero cells with KOS caused extensive frag-
mentation of Golgi-producing punctate staining throughout
the cytoplasm of infected cells (Fig. 10B), as previously
described (Campadelli et al., 1993; Avitabile et al., 1995).
In contrast, KOS infection of gK9 cells showed extensive
colocalization of Golgi and ER markers (Fig. 10C) indicat-
ing that dispersed Golgi structures had redistributed to the
ER. These results were analogous to those obtained when
KOS-infected Vero cells were treated with brefeldin A (Fig.
Fig. 7. Cell surface immunohistochemical detection of gD or gK using anti-gD or anti-V5 antibody, respectively. Vero, VK302, or gK9 cells were infected
with gKV5DI virus at an MOI of 5 and cells were immunohistochemically processed at 12 hpi under either live (A1, B1, C1, A3, B3, and C3), or fixed and
permeabilized (A2, B2, C2, A4, B4, and C4) conditions.
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10E). H89, a member of the isoquinolinesulfonamide group
of protein kinase inhibitors, exhibits selective inhibition of
protein kinases. H89 is known to revert hyposomotic and
brefeldin A-induced Golgi collapse to the ER (Lee and
Linstedt, 2000). H89 treatment of KOS-infected gK9 cells
prevented Golgi collapse, but did not prevent virus-induced
Golgi fragmentation (Fig. 10D). Thus, Golgi collapse in
gK9 cells seems to be similar to that produced by brefeldin
A inasmuch as both defects can be prevented by H89.
Discussion
Viral glycoproteins are major determinants in the orches-
tration of membrane-associated events required for efficient
viral replication of enveloped viruses. Herpesviruses, in
contrast to other enveloped viruses, have evolved elaborate
strategies to deal with cellular membranes during virus
entry, intracellular virion morphogenesis, and cell-to-cell
virus spread (Spear, 1993b). HSV-1 glycoproteins gB, gD,
gH, and gL are absolutely required for membrane fusion
events during virus entry as well as gB-mediated cell-to-cell
fusion (Muggeridge, 2000; Roop et al., 1993; Spear, 1993a,
1993b; Turner et al., 1998). However, most syncytial mu-
tations are within gB and gK, indicating that specific do-
mains of gB and gK participate in regulatory mechanisms
responsible for membrane fusion events during the her-
pessimplex life cycle. In particular, gK mutations exhibit a
unique set of phenotypes, which indicate that gK is involved
not only in virion-to-cell fusion (virus entry) and virus-
induced cell-to-cell fusion (syncytia formation), but even
more importantly in the regulation of intracellular virion
transport and egress (Bond and Person, 1984; Dolter et al.,
1994; Foster and Kousoulas, 1999; Hutchinson and John-
son, 1995; Jayachandra et al., 1997; Pogue-Geile et al.,
1984; Pogue-Geile and Spear, 1987). In this article, we
extend previous work performed by Hutchinson and John-
son, which was instrumental in the initial characterization of
gK and its role in cell fusion and virion intracellular trans-
port (Hutchinson et al., 1992; Hutchinson and Johnson,
1995). Overexpression of gK by gK-transformed cells in-
hibited gK-induced cell fusion and intracellular virion mat-
uration (Hutchinson et al., 1993; Hutchinson and Johnson,
1995). Similar results have been obtained with other cell
lines transformed with the UL53 gene encoding gK, such as
BL-1, which contains approximately 20 copies of gK under
its native promoter (Skepper et al., 2001; Foster, T.P., Kou-
soulas, K.G., unpublished data). The purpose of our inves-
tigations was to investigate the synthesis and transport of
gK as well as other viral glycoproteins in an attempt to
resolve the molecular basis for the observed inhibition of
gK-mediated cell fusion and intracellular virion transport by
gK-transformed cells. A profound inhibition of intracellular
transport and maturation of gD and gK, as well as pro-
nounced defects in Golgi-dependent glycosylation of gB,
were observed in gK9 cells. These results were analogous to
those observed in the presence of specific glycosylation and
glycoprotein transport inhibitors (Kousoulas et al., 1983;
Pizer et al., 1980; Whealy et al., 1991). Characterization of
the extent of carbohydrate processing of gK, gB, and gD
revealed that all three glycoproteins were not processed by
Golgi-dependent enzymes, since only immature carbohy-
drate chains characteristic of ER-based glycosylation were
present even at late time post infection of gK9 cells. Fur-
thermore, confocal visualization revealed localization of gK
and gD predominantly within the ER of gK9 cells. This
block in gK and gD transport at the ER in gK9 cells is
similar to the inhibition of viral glycoprotein synthesis and
transport produced in the presence of the chemical inhibi-
tors TM and BFA. In contrast to the total inhibition of
N-linked carbohydrate addition by TM, BFA allows for the
synthesis of high mannose precursor carbohydrates, but
these precursors cannot be further modified because brefel-
din induces a collapse of the Golgi apparatus into the ER
(Cheung et al., 1991; Doms et al., 1989; Whealy et al.,
1991).
Previous studies have indicated that inhibition of glyco-
protein synthesis and transport results in inhibition of the
intracellular transport and virion morphogenesis at different
Fig. 8. Differentiation of fully and underglycosylated gD (A), gB (B), or
gK (C) species specified by gKprotC-DIII virus. Immunoblots of gKprotC-
DIII-infected Vero, VK302, or gK9 cellular extracts treated with EndoH,
PNGaseF, or mock-treated.
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Fig. 9. Confocal microscopy of Vero (C, D, E, and F) or gK9 (A and B) cells infected with gKV5DI virus. Cell surfaces (red: D3, D4, F3, and F4) or ER
(red: A3, A4, B3, B4, C3, C4, E3, and E4) were labeled with biotin or conA, respectively. Infected Vero cells were treated with either BFA (C and D), or
TM (E and F) at 3 hpi. Anti-gD (green: A2, D2, E2, A4, B4, and E4) or anti-V5 (B2, B4, C2, C4, F2, and F4) were used to visualized gD and gK cellular
distribution, respectively. Corresponding DIC images of cells are as shown (A1, B1, C1, D1, E1, and F1). Superimposition of red, green, and blue images
for each group are shown (A4, B4, C4, D4, E4, and F4).
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cellular sites coinciding with the specific cellular organelles
affected by each inhibitor (Johnson and Spear, 1982; Kousou-
las et al., 1983a, 1983b; Pizer et al., 1980; Whealy et al., 1991).
Thus, both TM and BFA caused accumulation of virions into
perinuclear spaces, while at the same time blocking viral gly-
coprotein transport at the ER. In agreement with these findings,
the observed block in viral glycoprotein synthesis and transport
in infected gK9 cells entrapped KOS and MP virions within
perinuclear spaces. In contrast, inhibition of glycoprotein syn-
thesis by monensin at the Golgi apparatus causes entrapment of
enveloped virions in cytoplasmic vacuoles that most likely
originate from the TGN.
Fig. 10. Confocal microscopy of Vero (B and E) or gK9 (A, C, and D) cells either infected with HSV-1 (KOS) virus (B, C, D, and E) or mock-infected (A).
Golgi (green/yellow: A, B, C, and D) or ER (red/yellow: A, B, C, D, and E) were labeled with GS-II or conA, respectively. Infected cells (B, C, D, and E)
were treated with either BFA (E) or H89 (D).
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Surprisingly, tsB5 virions overcame the perinuclear
block in virion transport, producing enveloped virions
within cytoplasmic vacuoles as well as unenveloped capsids
within the cytoplasm. These results indicate that the gBsyn3
mutation enables efficient de-envelopment of tsB5 virions
into the cytoplasm, suggesting that gB functions in the
de-envelopment process. The gBsyn3 mutation may en-
hance the natural fusogenicity of gB or, alternatively, may
disengage gB from possible regulatory interactions with gK,
UL20, or other viral proteins functioning during de-envel-
opment. However, tsB5 virions remained entrapped within
TGN-derived vacuoles. A similar phenotype was observed
in Vero cells infected with the gK-null virus gK (Foster
and Kousoulas, 1999; Jayachandra et al., 1997). Therefore,
lack of gK transport to TGN compartments in gK9 cells
may cause a gK-null-like phenotype, further suggesting that
gK is essential for virus egress out of infected cells.
HSV-1 infection of Vero cells caused substantial frag-
mentation and dispersal of Golgi structures throughout the
cytoplasm of infected cells (Avitabile et al., 1995; Cam-
padelli et al., 1993). We show here that infection of gK9
cells leads to a profound Golgi collapse into ER causing
severe defects in intracellular virion maturation and glyco-
protein transport. These effects correlate with the levels of
gK mRNA, and presumably gK expression. However, it is
not clear whether gK directly causes the Golgi collapse or
initiates a cascade of events that indirectly lead to the Golgi
collapse via interfering with one or more cellular proteins.
Most likely, the observed inhibition of gK-mediated cell
fusion is due to lack of gK expression on gK9 cell surfaces.
In contrast, gB was readily detected on gK9 cell surfaces,
albeit at slightly reduced levels, explaining why gBsyn
mutants were capable of producing syncytial plaques in gK9
cells. These results with gK9 cells, were similar to the
differential cell surface expression of gD and gK in infected
Vero cells treated with brefeldin A (Fig. 9). Furthermore, it
has been shown that cell surface expression of certain viral
glycoproteins are not inhibited by brefeldin A, most likely
because they are transported directly to cell surfaces via
alternative transport pathways independent of Golgi-associ-
ated processing (Ogura et al., 2000). In addition, we have
shown that in the presence of inhibitors of Golgi-dependent
glycoprotein maturation such as NH4Cl, monensin, and
A23187, immature forms of gB and gD are transported to
HSV-1-infected cell surfaces (Person et al., 1982). The
relative size of gB-mediated syncytial plaques was reduced
by approximately 50% in gK9 cells in comparison to Vero
or VK302 cells. Virus-induced cell fusion by syncytial
mutations in gB require cell surface expression of gD as
well as gH and gL (Browne et al., 2001). Therefore, the
observed reductions in cell surface expression of either gD
or gB and/or their level of carbohydrate processing may be
responsible for the reduction of gB-mediated cell fusion. In
addition, it is possible that gK-specific inhibition of virus
spread from cell to cell also contributes to the production of
smaller syncytial viral plaques.
Previous studies have shown that UL20-null viruses are
entrapped within the perinuclear space indicating that UL20
is required for intracellular virion transport from perinuclear
spaces. The UL20 protein seems to be functionally associ-
ated with Golgi fragmentation and dispersal inasmuch as
UL20-null viruses cannot egress out of cells in which Golgi
are fragmented (Avitabile et al., 1995). Recently, we
showed that intracellular transport and cell surface expres-
sion of gK required coexpression of UL20 (Foster et al.,
2003). Similarly, gK specified by PRV required coexpres-
sion of UL20 for efficient Golgi-dependent processing (Di-
etz et al., 2000). These results suggest that the UL20 protein
interacts with gK. Therefore, high levels of gK may inhibit
the formation of appropriate protein complexes between
gK, UL20, and/or other viral proteins required for coordi-
nate transport of glycoproteins and virions to the Golgi as
well as optimization of Golgi-dependent functions and/or
stabilization of Golgi structure necessary for efficient virus
egress.
Collectively, these and previous investigations have in-
dicated that without any exception inhibition of intracellular
transport pathways causes profound effects on virion mat-
uration and egress. Furthermore, intracellular virion mor-
phogenesis and egress as well as glycoprotein transport are
highly dependent on preservation and optimization of the
Golgi apparatus. Given the fact that herpesviruses possess
multiple strategies to modify the cellular milieu to their
advantage, it can be argued that herpesviruses must encode
mechanisms responsible for the optimization of cellular
intracellular organelles such as the Golgi as well as cellular
membrane trafficking systems to ensure efficient virion mat-
uration and egress. Such virally encoded strategies must
involve gK, UL20, as well as other viral proteins, which
may not only regulate specific steps in virion maturation,
but may also have important roles in the preservation and
enhancement of intracellular organelles and membrane-traf-
ficking systems.
Materials and methods
Cells and viruses
African green monkey kidney (Vero) cells were obtained
from ATCC (Rockville, MD). Cells were propagated and
maintained in Dulbecco’s modified Eagle’s medium
(DMEM; Sigma Chemical Co., St. Louis, MO) containing
sodium bicarbonate, 15 mM HEPES, and supplemented
with 7% heat-inactivated fetal bovine serum (FBS). The
gK-transformed cell lines VK302 and gK9 were a generous
gift from Dr. D.C. Johnson (Oregon Health Sciences Uni-
versity) and were maintained in DMEM lacking histidine
and supplemented with 0.3 mM histidinol (Hutchinson et
al., 1993). The parental wild-type strain used in this study,
HSV-1 (KOS), was originally obtained from P.A. Schaffer
(Harvard Medical School). The KOS-EGFP, tsB5-EGFP,
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and MP-EGFP viruses constitutively express the green flu-
orescence protein from an intergenic locus and were as
described previously (Foster et al., 1999; Foster et al.,
2001a). The UL53-gK protein C epitope tagged virus
gKprotC, and the V5 epitope containing virus gKV5DI,
were propagated in Vero cells as described previously (Fos-
ter et al., 2003; Foster et al., 2001b).
Real-time quantitative RT-PCR
Vero, VK302, and gK9 cells were either infected at an
MOI of 10 with wild-type KOS virus or mock-infected.
Total RNA from each cell line was extracted in triplicate
with TriReagent according to the manufacturer’s directions.
To control for pipetting errors, RNA samples and reaction
mixes were automatically aliquoted using a MagNA Pure
LC robotic delivery system (Roche, Inc.). Taqman probes
and primers for the quantitative detection of the gK target
mRNA were designed by using Primer Express computer
software (Applied Biosystems). During amplification, an
ABI-Prism 7700 sequence detector monitored real-time
PCR amplification by quantitatively analyzing fluorescence
emissions. Samples were analyzed in triplicate on three
independent runs. The CT value is defined as the cycle
number in which the detected fluorescence exceeded an
established threshold level that was kept constant in all
experiments (Heid et al., 1996). Validation experiments
were performed to demonstrate that the efficiencies of am-
plification of target and reference were approximately
equal. Fold differences in expression of gK relative to un-
infected or KOS-infected Vero cells were calculated by the
comparative CT method, where each CT was normalized to
the endogenous cellular control 18s ribosomal RNA (rRNA)
obtained using the TaqMan ribosomal control reagent kit
(Perkin Elmer):
Fold difference 2CT (1)
Fold difference 2deltaCT1deltaCT2 (2)
Fold difference
 2CT1(target)CT1(rRNA1)CT2(calibrator)CT2(rRNA/calibrator) (3)
where CT1(target) represents the CT values of the gK mR-
NAs from each cell line and CT2(calibrator) represents the
CT values from either uninfected Vero cells or KOS-in-
fected Vero cells. CT1(rRNA1) and CT2(rRNA/calibrator)
represent the CT values for the rRNA controls for each
respective sample (Hamalainen et al., 2001).
One-step growth kinetics
Analysis of one-step growth kinetics was as described
previously (Foster et al., 2001b, 2003). Briefly, each virus at
an MOI of 5 was adsorbed to approximately 8  105 cells
of the indicated cell line at 4°C for 1 h. Thereafter, pre-
warmed medium was added and virus was allowed to pen-
etrate for 2 h at 37°C. Any remaining extracellular virus was
inactivated by low-pH treatment (0.1 M glycine, pH 3.0).
Cells and supernatants were harvested immediately there-
after (0 h) or after 4-, 8-, 12-, or 24-h incubations at 37°C.
Virus titers were determined by end point titration of virus
stocks on Vero cells.
Relative plaquing efficiency and plaque morphology
Relative plaquing efficiencies were determined in tripli-
cate by plating 1  108 plaque forming units of KOS, tsB5,
or MP viruses at 1:10 dilutions on Vero, VK302, or gK9 cell
lines. Plaques were counted at 48 hpi and plaquing efficien-
cies were calculated in comparison to Vero cells. For plaque
morphology of EGFP containing viruses on Vero- and gK-
transformed cells, VK302 and gK9 cells were infected at an
MOI of 0.001 with KOS-EGFP, tsB5-EGFP, or MP-EGFP
and visualized by fluorescence microscopy at 36 hpi. All
experiments were performed at 37°C.
Transfections
Subconfluent cells in six-well plates were transfected
with the indicated plasmids utilizing the Lipofectamine
2000 reagent (Invitrogen) according to the manufacturer’s
directions. Cells were processed for Western analysis at
12 h post transfection.
Western analysis of protein expression
Subconfluent cell monolayers were infected with gK-
protC-DIII at an MOI of 5. Cells were collected by low
speed centrifugation at 24 hpi, washed with TBS, and lysed
at room temperature for 15 min in Mammalian Protein
Extraction Reagent (MPER) supplemented with a cocktail
of protease inhibitors (Invitrogen-Life Technologies, Carls-
bad, CA). Insoluble cell debris was pelleted and samples
were treated with endoglycosidase H (Endo-H) or peptide:
N-glycosidase F (PNGase F) as described previously (Fos-
ter et al., 2001b, 2003). Samples were electrophoretically
separated by SDS-PAGE, transferred to nitrocellulose
membranes, and probed with either anti-protC monoclonal
antibody (mAb) HPC-4 at 1:50 dilution (ATCC CRL #HB-
9892) for detection of gK, RGI#1103 for detection of gD, or
RGI#1105 for detection of gB. Subsequently, blots were
incubated for 1 h with a peroxidase-conjugated secondary
antibody at a 1:50,000 dilution and visualized on x-ray film
by chemiluminescence (Pierce Chemical, Rockford, IL)
(Foster et al., 2001b, 2003). All antibody dilutions and
buffer washes were performed in Tris-buffered saline (TBS)
supplemented with 0.135 M CaCl2 and 0.11 M MgCl2
(TBS-Ca/Mg).
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Electron microscopy
Cell monolayers were infected at an MOI of 5 and where
indicated, glycoprotein transport inhibitors were added at 3
hpi. All cells were prepared for TEM examination 16 hpi.
Infected cells were fixed in a mixture of 2% paraformalde-
hyde and 1.5% glutaraldehyde in 0.1 M NaCaC buffer, pH
7.3. Following osmication (1% OsO4) and dehydration in an
ethanol series, the samples were embedded in Epon-
Araldyte resin and polymerized at 70°C. Thin sections were
made on an MTXL Ultratone (RMC Products), stained with
5% uranil acetate and CNA lead, and observed with a Zeiss
10 transmission electron microscope.
Confocal microscopy
Cell monolayers grown on coverslips in six-well plates
were infected with the indicated virus at an MOI of 10. Cells
were washed with TBS and fixed with electron microscopy
(EM) grade 3% paraformaldehyde (Electron Microscopy
Sciences, Fort Washington, PA) for 15 min at 12 hpi,
washed twice with PBS-50 mM glycine, and permeabilized
with 0.1% Triton X-100. Alternatively, for cell surface
biotinylation, prior to fixation cells were rinsed and incu-
bated in EZ-Link Sulfo-NHS-LC Biotin cell-impermeable
biotinylation reagent (Pierce Chemical), which reacts with
primary amines on cell surface proteins, for 15 min at RT.
Monolayers were subsequently blocked for 1 h with 5%
normal goat serum and 5% BSA in TBS (TBS-blocking
buffer) before incubation for 5 h with either FITC-conju-
gated anti-V5 (Invitrogen), anti-gD, or anti-gB (Rumbaugh-
Goodwin Institute, Plantation, FL) diluted 1:500 in TBS-
blocking buffer. Cells were then washed extensively and
subsequently incubated for 1 h with a mixture of Alexafluor
488-conjugated anti-IgG and Alexafluor 488 anti-FITC
(Vector Laboratories) diluted 1:500 in TBS-blocking buffer
for FITC-conjugated anti-V5 or Alexafluor 488-conjugated
anti-IgG diluted 1:500 for anti-gB. After incubation, excess
antibody was removed by washing five times with TBS. The
nucleus was counterstained using TO-PRO3 iodide (1:5000
dilution) and visualized in the blue channel. For cell surface
labeling, biotinylated cells were reacted with 1:1000 diluted
Alexafluor 568-conjugated streptavidin for 20 min and vi-
sualized in the red channel. To visualize ER staining within
the red channel, cells were incubated with a 1:1500 dilution
of the lectin concanavalin A conjugated with Alexafluor
568. To visualize Golgi and ER simultaneously, Golgi and
ER membranes were stained with either Alexafluor 488-
conjugated GS-II or Alexafluor 568-conjugated conA, re-
spectively, as described previously (Foster et al., 2003;
Cottin et al., 1999; Lee et al., 2000). Cells were examined
using a Leica TCS SP2 laser scanning microscope (Leica
Microsystems, Exton, PA) fitted with a 100 Leica objec-
tive (Planachromatic; 1.4 numerical aperature). Individual
optical sections in the z-axis, averaged 8 times, were col-
lected simultaneously in the different channels at 512 512
pixel resolution as described previously (Foster et al., 2003).
Images were compiled and rendered in Adobe Photoshop.
Immunohistochemistry
Cell monolayers in six-well plates were infected with the
indicated virus at an MOI of 5 and incubated at 37°C for
12 h. Infected monolayers were washed with TBS-Ca/Mg
and either fixed with EM grade 3% paraformaldehyde or left
unfixed (live). Immunohistochemistry was performed utiliz-
ing Vector Laboratories Vectastain Elite ABC kit according
to the manufacturer’s directions and as described previously
(Foster et al., 2003).
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